CD3 Antibody and IL-2 Complex Combination Therapy Inhibits Atherosclerosis by Augmenting a Regulatory Immune Response

Journal of the American Heart Association - United Kingdom
doi 10.1161/jaha.113.000719
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Oral Anti-Cd3 Antibody Treatment Induces Regulatory T Cells and Inhibits the Development of Atherosclerosis in Mice

Circulation
Cardiovascular MedicinePhysiologyCardiology
2009English

Measles Virus Nucleoprotein Induces a Regulatory Immune Response and Reduces Atherosclerosis in Mice

Circulation
Cardiovascular MedicinePhysiologyCardiology
2007English

IL-2/CD25: A Long-Acting Fusion Protein That Promotes Immune Tolerance by Selectively Targeting the IL-2 Receptor on Regulatory T Cells

Journal of Immunology
AllergyImmunology
2018English

The Immune Response Suppressed by Specific Antibody

Transplantation
Transplantation
1970English

Natural Killer Cell Expansion With Autologous Feeder Layer and Anti-Cd3 Antibody for Immune Cell Therapy of Hepatocellular Carcinoma

Asian Pacific Journal of Cancer Prevention
2019English

Combination Approaches to Potentiate Immune Response After Photodynamic Therapy for Cancer

Photochemical and Photobiological Sciences
Theoretical ChemistryPhysical
2011English

5-Aza-2′-Deoxycytidine Potentiates Antitumour Immune Response Induced by Photodynamic Therapy

European Journal of Cancer
Cancer ResearchOncology
2014English

Theranostic Evaluation of the Combination of Hypofractionated Radiation Therapy and IL-2/anti-IL-2 Complexes in Tumor-Bearing Mice

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

IL-2/anti-IL-2 Antibody Complexes Show Strong Biological Activity by Avoiding Interaction With IL-2 Receptor Subunit CD25

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy